branaplam development codes pyridazine derivative studied experimental drug originally developed novartis treat spinal muscular atrophy sma since developed treat huntingtons disease hd trial ended harmful side treatment sma branaplam increases amount functional survival motor neuron protein produced gene modifying splicing studied since clinical trial children sma type programme discontinued october novartis announced branaplam lowers level huntingtin protein one major therapeutic approaches huntingtons disease us food drug administration fda granted orphan drug status branaplam treatment huntington disease novartis announced set clinical trials december branaplam received fast track designation fda towards phase iib study adult patients earlystage hd drug article relating musculoskeletal system stub help wikipedia expanding ithttpsenwikipediaorgwikibranaplam